FIA
SRRA

FNY Investment Advisers’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History

FNY Investment Advisers’s Portfolio SRRA Stock Details SRRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-269
Closed -$14K – 980
2022
Q2 		$14K Buy
+269
New +$14.1K 0.01% 375

Other funds holding SRRA

HI
Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return

FNY Investment Advisers's SRRA Position: Q3 2022 in Review

FNY Investment Advisers sold out of Sierra Oncology, Inc. Common Stock (SRRA) in Q3 2022, closing a stake of 269 shares — an estimated $14K sold.

FNY Investment Advisers first reported a position in SRRA in Q2 2022 and held it in 1 quarter. The position peaked at $14K in Q2 2022. 1 fund tracked by Wall St. Rank holds SRRA as of Q3 2022.

  • FNY Investment Advisers reported no remaining Sierra Oncology, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • FNY Investment Advisers sold 269 Sierra Oncology, Inc. Common Stock shares in Q3 2022, an estimated $14K.
  • FNY Investment Advisers first reported a position in Sierra Oncology, Inc. Common Stock in Q2 2022 and held it in 1 quarter.
  • FNY Investment Advisers's Sierra Oncology, Inc. Common Stock position peaked at $14K in Q2 2022.
  • 1 fund tracked by Wall St. Rank held Sierra Oncology, Inc. Common Stock as of Q3 2022.

Based on FNY Investment Advisers's 13F filing for Q3 2022, filed 19 Oct 2022.